[1]
Güner, M.E. et al. 2025. Predictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7. Dermatology Practical & Conceptual. 15, 4 (Oct. 2025), 6169. DOI:https://doi.org/10.5826/dpc.1504a6169.